EMEA-002287-PIP01-17-M02

Table of contents

Key facts

Active substance
Cotadutide
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0270/2021
PIP number
EMEA-002287-PIP01-17-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Subcutaneous use
Contact for public enquiries
AstraZeneca AB

Email: paediatrics@astrazeneca.com
Tel. +46 855327591
 

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating